CPDD 78th Annual Scientific Meeting Program
2016-78th-CPDD-Program-Book-6-07-16FINAL
2016-78th-CPDD-Program-Book-6-07-16FINAL
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
June 14, 2016 Fiesta<br />
June 14, 2016 Fiesta<br />
Tuesday, June 14, 2016<br />
Oral Communications 9 Tuesday,<br />
SON OF FLUBBER: CHEMISTRY<br />
Chairs: Jun Zhu and Linda Dwoskin<br />
4<br />
2:15 - 3:15 PM<br />
2:15 Tyrosine470 and 88 of human dopamine transporter are responsible for the allosteric<br />
modulatory effect of SRI-30827, SRI-20041 and HIV-1 Tat protein on dopamine transporter<br />
J. Zhu 1 , W. Sun 2 , S. Ananthan 4 , C. Zhan 5 , 1 Drug Discovery and Biomedical Sciences, South<br />
Carolina College of Pharmacy, University of South Carolina, Columbia, SC, 2 Drug Discovery<br />
and Biomedical Sciences, University of South Carolina, Columbia, SC, 4 Organic Chemistry,<br />
Southern Research Institute, Birmingham, AL<br />
2:30 Oral JPC-077, a vesicular monoamine transporter-2 inhibitor, reduces methamphetamine<br />
self-administration across repeated treatments<br />
A. Wilson 3 , N. Lee 2 , J. R. Nickell 2 , J. P. Culver 2 , V. Janganati 4 , G. Zheng 4 , P. A. Crooks 4 ,<br />
L. P. Dwoskin 2 , M. T. Bardo 3 , 2 Pharmaceutical Sciences, University of Kentucky,<br />
Lexington, KY, 3 Psychology, University of Kentucky, Lexington, KY, 4 University of<br />
Arkansas for Medical Sciences, Little Rock, AR<br />
2:45 Stereoselective differences in the reinforcing effects of “bath salts” constituent<br />
3,4-methylenedioxypyrovalerone under a progressive ratio schedule of reinforcement in rats<br />
B. M. Gannon 1 , K. Galindo 1 , K. Rice 2 , G. T. Collins 1,3 , 1 Pharmacology, University of Texas<br />
Health Science Center at San Antonio, San Antonio, TX, 2 Chemical Biology Research<br />
Branch, NIDA and NIAAA, Bethesda, MD, 3 South Texas Veterans Health Care System,<br />
San Antonio, TX<br />
3:00 Investigation of the κ-opioid receptor agonist CR845 and reference comparator, butorphanol, in<br />
rats trained to discriminate (-) pentazocine from saline<br />
D. J. Heal 2 , J. Gosden 2 , N. Slater 2 , R. H. Spencer 1 , F. Menzaghi 1 , 1 Cara Therapeutics,<br />
Shelton, CT, 2 RenaSci Ltd, Nottingham, United Kingdom<br />
Oral Communications 10 Tuesday,<br />
SHAWSHANK REDEMPTION: CRIMINAL JUSTICE<br />
Chairs: Carlos C. Mahaffey and David S. Festinger<br />
12<br />
2:15 - 3:15 PM<br />
2:15 Attitudes and practices on the use of extended-release naltrexone in criminal justice settings<br />
D. S. Festinger 1 , K. L. Dugosh 1 , D. R. Gastfriend 3 , C. Sierka 1 , 1 Law and Ethics, Treatment<br />
Research Institute, Philadelphia, PA, 3 Treatment Research Institute, Philadelphia, PA<br />
2:30 An evaluation of opioid substitution treatment in prison on risk of mortality in period<br />
immediately after prison: Does leaving prison on OST reduce the risk of death?<br />
G. Stillwell 1 , H. Jones 2 , J. Shaw 3 , M. Farrell 4 , J. Marsden 1 , 1 National Addiction Centre,<br />
Institute of Psychiatry, Kings College London, London, United Kingdom, 2 School of Social<br />
and Community Medicine, University of Bristol, Bristol, United Kingdom, 3 Institute of Brain,<br />
Behaviour and Mental Health, University of Manchester, Manchester, United Kingdom,<br />
4<br />
National Drug and Alcohol Research Centre, University of New South Wales, Sydney, NSW,<br />
Australia<br />
2:45 Alcohol and cocaine use and drug distribution among formerly incarcerated black men<br />
C. C. Mahaffey 2 , D. Stevens-Watkins 1 , C. Leukefeld 3 , 1 Spalding University, Louisville, KY,<br />
2<br />
University of Kentucky, Lexington, KY, 3 Behavioral Science, University of Kentucky,<br />
Lexington, KY<br />
66